Levoketoconazole N-Oxide - Request Quote
Levoketoconazole N-Oxide
| SZ CAT No: | SZ-K001051 |
| CAS No | NA |
| Mol.F. | C26H28Cl2N4O5 |
| Mol.Wt. | 547.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Levoketoconazole N-Oxide is chemically 1-(4-(((2S,4R)-2-((1H-imidazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-acetylpiperazine 1-oxide. Levoketoconazole N-Oxide is supplied with detailed characterization data compliant with regulatory guideline. Levoketoconazole N-Oxide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ketoconazole.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Levoketoconazole N-Oxide
Purchase Levoketoconazole N-Oxide
Levoketoconazole N-Oxide suppliers
Levoketoconazole N-Oxide manufacturers
Levoketoconazole N-Oxide price
Order Levoketoconazole N-Oxide
Enquire Levoketoconazole N-Oxide
Levoketoconazole N-Oxide cost
Levoketoconazole N-Oxide Supplier
Levoketoconazole N-Oxide Distributor
Levoketoconazole N-Oxide for Method Validation
Ketoconazole Reference Standard
Levoketoconazole N-Oxide for ANDA Filing
Levoketoconazole N-Oxide for Forced Degradation Studies
Levoketoconazole N-Oxide Identification Standards
Levoketoconazole N-Oxide for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


